<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2026-02-01</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2026-02-01</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>103</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
*   <strong>spaTransfer</strong>ï¼šæ–°å‹è¿ç§»å­¦ä¹ æ–¹æ³•ï¼Œå¯æœ‰æ•ˆæ•´åˆå•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„æ•°æ®ï¼Œå…‹æœä¸åŒæŠ€æœ¯å¹³å°å’Œç‰©ç§é—´çš„å·®å¼‚ã€‚<br />
*   <strong>KRASæŠ‘åˆ¶è”åˆæ²»ç–—</strong>ï¼šåœ¨èƒ°è…ºç™Œå’Œå°ç»†èƒè‚ºç™Œä¸­ï¼Œè”åˆé¶å‘KRASå’ŒEZH2æˆ–é€šè¿‡è¡€ç®¡STINGæ¿€æ´»ï¼Œå‡æ˜¾ç¤ºå‡ºä¿ƒè¿›è‚¿ç˜¤å…ç–«æˆ–æŠ‘åˆ¶è‚¿ç˜¤ç”Ÿé•¿çš„æ½œåŠ›ã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§</strong>ï¼šç ”ç©¶KRAS/EZH2æŠ‘åˆ¶ã€NKç»†èƒæ¿€æ´»ã€IFN-Î³ä¿¡å·é€šè·¯åœ¨èƒ°è…ºç™Œã€è‚ºç™Œã€ä¹³è…ºç™Œã€ç–Ÿç–¾æ¨¡å‹ä¸­çš„ä½œç”¨ã€‚<br />
*   <strong>å¿ƒè¡€ç®¡ç–¾ç—…æœºåˆ¶æ¢ç´¢</strong>ï¼šæ­ç¤ºç»„èƒºN-ç”²åŸºè½¬ç§»é…¶å’ŒKLF15åœ¨å¿ƒè„è‚¥å¤§ã€å¿ƒåŠ›è¡°ç«­ä¸­çš„ç—…ç†ç”Ÿç†ä½œç”¨ã€‚<br />
*   <strong>è‚¿ç˜¤å‘ç”Ÿä¸ä»£è°¢äº’ä½œ</strong>ï¼šå…³æ³¨ç³–é†›é…¸é…¶1è¡¨è¾¾ã€ç”˜é†›è¯±å¯¼çš„è‚¿ç˜¤åº”æ¿€ï¼Œä»¥åŠæ˜Ÿå½¢èƒ¶è´¨ç»†èƒ-çº¿ç²’ä½“ç©¿æ¢­åœ¨èƒ¶è´¨æ¯ç»†èƒç˜¤æ¿€æ´»å’Œå…ç–«é€ƒé€¸ä¸­çš„ä½œç”¨ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>spaTransfer</strong>ï¼šåˆ©ç”¨éè´ŸçŸ©é˜µåˆ†è§£å®ç°å•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„æ•°æ®çš„è·¨å¹³å°ã€è·¨ç‰©ç§è¿ç§»å­¦ä¹ ã€‚<br />
*   <strong>å¤šç»„å­¦æ•´åˆ</strong>ï¼šç»“åˆRNA-seqã€ChIP-seqã€CUT&amp;Tagã€Bisulfite-Seqç­‰æŠ€æœ¯ï¼Œæ·±å…¥è§£æè‚¿ç˜¤å¾®ç¯å¢ƒã€è¡¨è§‚é—ä¼ è°ƒæ§åŠä»£è°¢é€šè·¯ã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
RNAæµ‹åºæŠ€æœ¯æ­ç¤ºé˜¿å°”èŒ¨æµ·é»˜ç—…ï¼ˆADï¼‰çš„ä»£è°¢ä¸çªè§¦æ”¹å˜ï¼Œå¹¶å‘ç°ä½å‰‚é‡THCè”åˆå¡æ¥æ˜”å¸ƒå¯èƒ½æ”¹å–„ADã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
- æ¢ç´¢ADçš„è¡€æ¶²ç”Ÿç‰©æ ‡å¿—ç‰©ï¼Œå…³æ³¨ä»£è°¢å’Œçªè§¦åŸºå› è¡¨è¾¾ã€‚<br />
- ç ”ç©¶THCä¸å¡æ¥æ˜”å¸ƒè”åˆæ²»ç–—å¯¹ADå°é¼ æ¨¡å‹ç‚ç—‡å’Œçªè§¦åŠŸèƒ½çš„å½±å“ã€‚<br />
- æ­ç¤ºèƒ°è…ºç™Œé€šè¿‡è°ƒæ§å¾®ç¯å¢ƒï¼ˆå¦‚åˆ©ç”¨å‘¨çš®è´¨ç´ ï¼‰ä¿ƒè¿›ç¥ç»ä¾µè¢­å’Œè½¬ç§»çš„æœºåˆ¶ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
- åº”ç”¨RNAæµ‹åºæŠ€æœ¯æ·±å…¥è§£æADçš„åˆ†å­æœºåˆ¶ã€‚<br />
- é¦–æ¬¡å‘ç°èƒ°è…ºç™Œåˆ©ç”¨å‘¨çš®è´¨ç´ é‡å¡‘ç»„ç»‡ä»¥å®ç°å¿«é€Ÿä¾µè¢­ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (100æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE315131 è”åˆæŠ‘åˆ¶ EZH2 å’Œ KRAS åèƒ°è…ºç™Œå…ç–«å¾®ç¯å¢ƒå˜åŒ–çš„å•ç»†èƒ RNA æµ‹åºåˆ†æ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€RNA-seqã€single-cellã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusOur study demonstrated that combined treatment with the EZH2 inhibitor tazemetostat and the KRAS inhibitor RMC-6236 significantly suppressed the growth of both subcutaneous and orthotopic tumors. To investigate changes in the tumor microenvironment following combined EZH2 and KRAS inhibition in pancreatic cancer, mice bearing subcutaneous KPC tumors were treated with vehicle, RMC-6236 alone, or RMC-6236 in combination with tazemetostat. CD45âº cells were isolated and subjected to 10Ã— Genomics single-cell RNA sequencing.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315131" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE318080 è¡€ç®¡STINGæ¿€æ´»ä¿ƒè¿›NKç»†èƒåœ¨å°ç»†èƒè‚ºç™Œä¸­çš„æŠ—è‚¿ç˜¤å…ç–«</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€NK cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Marco Campisi ; Talal El Zarif ; Jacob E Berchuck ; Zhaorong Li ; Matthew Freedman ; Michael Y Tolstorukov ; David A Barbie ; Navin R MahadevanSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensSmall cell lung cancer (SCLC) typically displays a "cold" tumor microenvironment with a paucity of immune infiltrate. Neuroendocrine SCLC cells also profoundly repress MHC-I expression, rendering them vulnerable to NK cell-mediated cytotoxicity. Here, we confirm that neuroendocrine SCLC cells are sensitive to NK cell mediated attack, yet quantitative spatial profiling of the SCLC immune microenvironment in patient samples reveals that effector immune cells, including NK cells, are excluded from MHC-Ilow/neg SCLC regions. To study this biology, we develop dynamic single cell RNA sequencing of microphysiological immune tumor environments (DynaMITE-seq) and integrate findings with spatial transcriptomics in patient tissue, unveiling the microvasculature as a major checkpoint restricting NK cell extravasation/recruitment. We demonstrate that activation of vascular Stimulator of Interferon Genes (STING) signaling restores NK cell infiltration and killing of neuroendocrine SCLC, suggesting a strategy to overcome this key SCLC immunologic barrier and prime therapeutic response to DLL3-targeted CAR-NK cell therapy.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318080" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE317381 spaTransferï¼šä½¿ç”¨éè´ŸçŸ©é˜µåˆ†è§£è¿›è¡Œå•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦æ•°æ®çš„è¿ç§»å­¦ä¹  [DG]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Cindy Fang ; Kelsey D Montgomery ; Sarah E Maguire ; Anthony D Ramnauth ; Boyi Guo ; Sarah E Maguire ; Ryan A Miller ; Annie B Nguyen ; Joel E Kleinman ; Thomas M Hyde ; Heena R Divecha ; Keri Martinowich ; Kristen R Maynard ; Stephanie C Page ; Stephanie C Page ; Stephanie C HicksSeries Type : OtherOrganism : Homo sapiensRecent advances in spatially-resolved transcriptomics have enabled profiling of gene expression in a spatial context, which has led to the generation of large-scale single-cell and spatial atlases with computationally-derived cell type or spatial domain labels. An increasingly important task with these data has become the transfer of cell type or spatial domain annotations from a given reference (or source) atlas into a new target tissue or sample. The reference and target datasets could be at different resolutions or measured on different experimental platforms. Here, we present a method to perform cross-platform transfer learning that takes as input single-cell or spatial domain labels from a reference atlas or dataset and transfers the labels to a target dataset at a similar or different resolution. Specifically, we use non-negative matrix factorization (NMF) on the reference data to identify factors associated with labels of interest and project these factors into the target dataset to label each new observation. We use a multinomial model with the factors as covariates and labels as the response to predict labels in the target dataset. In contrast to existing approaches, the advantage of our approach is interpretability, without compromising on accuracy. We demonstrate the performance of the method in two human brain tissues and show that our model identifies spatially coherent domains in the target datasets with concordance of marker gene expression. We implement spaTransfer in open-source software as an R package (github.com/cindyfang70/spaTransfer).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317381" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE317379 spaTransferï¼šåˆ©ç”¨éè´ŸçŸ©é˜µåˆ†è§£è¿›è¡Œå•ç»†èƒå’Œç©ºé—´è½¬å½•ç»„å­¦æ•°æ®çš„è¿ç§»å­¦ä¹ </strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsingle-cellã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Cindy Fang ; Kelsey D Montgomery ; Sarah E Maguire ; Anthony D Ramnauth ; Boyi Guo ; Sarah E Maguire ; Ryan A Miller ; Annie B Nguyen ; Joel E Kleinman ; Thomas M Hyde ; Heena R Divecha ; Keri Martinowich ; Kristen R Maynard ; Stephanie C Page ; Stephanie C Page ; Stephanie C HicksSeries Type : OtherOrganism : Homo sapiensRecent advances in spatially-resolved transcriptomics have enabled profiling of gene expression in a spatial context, which has led to the generation of large-scale single-cell and spatial atlases with computationally-derived cell type or spatial domain labels. An increasingly important task with these data has become the transfer of cell type or spatial domain annotations from a given reference (or source) atlas into a new target tissue or sample. The reference and target datasets could be at different resolutions or measured on different experimental platforms. Here, we present a method to perform cross-platform transfer learning that takes as input single-cell or spatial domain labels from a reference atlas or dataset and transfers the labels to a target dataset at a similar or different resolution. Specifically, we use non-negative matrix factorization (NMF) on the reference data to identify factors associated with labels of interest and project these factors into the target dataset to label each new observation. We use a multinomial model with the factors as covariates and labels as the response to predict labels in the target dataset. In contrast to existing approaches, the advantage of our approach is interpretability, without compromising on accuracy. We demonstrate the performance of the method in two human brain tissues and show that our model identifies spatially coherent domains in the target datasets with concordance of marker gene expression. We implement spaTransfer in open-source software as an R package (github.com/cindyfang70/spaTransfer).<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317379" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE283333 å…¨é¢å…ç–«åˆ†ææ­ç¤º IFN-Î³ ä¿¡å·é€šè·¯åœ¨ T ç»†èƒä»‹å¯¼å•®é½¿åŠ¨ç‰©ç–Ÿç–¾æ¨¡å‹ä¸­çš„å¯„ç”Ÿè™«åå™¬ä½œç”¨ï¼šç©ºé—´è½¬å½•ç»„å­¦æ•°æ®</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€spatialã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jingwen Lin ; Shasha Chen ; Qingxin YangSeries Type : OtherOrganism : Mus musculusMalaria-associated lung pathology, a severe and life-threatening manifestation of Plasmodium infection, involves complex immune remodeling within the pulmonary microenvironment. To resolve the spatial architecture of this immune response, we performed spatial transcriptomic analysis on lung tissues from a Plasmodium berghei NK65-induced rodent model. Our study identifies IFN-Î³ signaling in T cells as a pivotal regulator of the lung's spatial immune landscape. By utilizing conditional knockout (cKO) mice lacking Ifngr1 specifically in T cells, we observed that the blockade of T cell-intrinsic IFN-Î³ signaling attenuates lung pathology. Spatially, this protection is characterized by an enriched colocalization and enhanced interaction between T cells and monocytes. This robust interaction drives the expansion of a unique proinflammatory monocyte subset defined by CD8 and Ly6C expression within specific pulmonary niches. These CD8+ Ly6C+ monocytes exhibit significantly enhanced phagocytic capacity and elevated MHCII expression in situ. Our spatially resolved findings illustrate that the T cell-IFN-Î³ signaling axis dictates the spatial organization of T cell-monocyte communication, highlighting this interaction as a potential therapeutic target for mitigating malaria-induced lung injury.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283333" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE305842 å¯¹å…ç–«ç–—æ³•ååº”ä¸åŒçš„ä¸‰é˜´æ€§ä¹³è…ºç™Œå°é¼ æ¨¡å‹ [scRNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€regex:immuno(logy|therapy|suppression)ã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Thomas J Kalantzakos ; Yufan Zhou ; Xingyu Liu ; Joshua Proehl ; Cameron Durfee ; Ian Tamayo ; Nuri Temiz ; Benjamin Troness ; Anusha Soni ; Harshita B Gupta ; Reuben S HarrisSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusBreast cancer is the most common cancer diagnosis in women. Clinical studies with triple-negative breast cancer (TNBC) are encouraging for immunotherapy combined with chemotherapy (aPD-1 with paclitaxel and/or carboplatin). However, additional clinical advances may be pursued more rapidly with assistance from preclinical TNBC models including syngeneic mammary tumor cell lines. Here, we report two mammary tumor cell lines that exhibit differential responsiveness to immunotherapy in vivo. Spontaneous mammary tumors from C57BL/6J MMTV-Cre Trp53fl/+ animals were passaged serially in cell culture and in vivo in the mammary fat pad of fully wildtype animals. The resulting lines, MM001i and MM008i, lost Trp53 and formed 1000 mm3 tumors in the mammary fat pad within 21-28 days. Despite originating from the same genetic background, these lines exhibit differential responses to immunotherapy. For aPD-1 therapy, MM001i is poorly responsive and MM008i is strongly responsive with near-complete tumor regression. In comparison, both MM001i and MM008i respond rapidly to aCTLA-4 therapy. Both models express unique tumor antigens as evidenced by immunity to subsequent engraftments. Primary MM008i tumors exhibit greater T cell infiltration, and CD8-positive T lymphocytes are required for aPD-1 responses. These TNBC models are promising for further mechanistic studies and testing future single and combinatorial therapies.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305842" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE307584 ç»„èƒº N-ç”²åŸºè½¬ç§»é…¶å¼‚å¸¸ä¸Šè°ƒé€šè¿‡ç ´å SAM/Frizzled-2/CaMKII ä¿¡å·é€šè·¯åŠ å‰§ç—…ç†æ€§å¿ƒè„è‚¥å¤§å’Œå¿ƒåŠ›è¡°ç«­ [RNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcardiacã€RNA-seqã€pathway<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Jinyan Zhang ; Hao Jiang ; Liwei Liu ; Xin Li ; Jing Yang ; Junbo Ge ; Aijun SunSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusMetabolites produced during the development of pathological cardiac hypertrophy and heart failure can influence disease progression. Methyl donor S-adenosyl methionine (SAM) levels are decreased in the hypertrophic heart, but related mechanisms and effects remain unknown. Histamine N-methyltransferase (HNMT) uses SAM as a substrate to deactivate histamine into N-methylhistamine. Here, we prove that HNMT was upregulated in cardiac tissues from patients with heart failure and post-transverse aortic constriction (TAC) mice as well as phenylephrine (PE)-treated neonatal mouse cardiomyocytes (NMCMs). N-methylhistamine, downstream metabolite of HNMT, was elevated in urine samples from heart failure patients. In mice, cardiomyocyte-specific Hnmt deletion ameliorated pathological cardiac hypertrophy and heart failure caused by TAC or Angiotensin-II infusion. Pharmacological inhibition of HNMT with amodiaquine ameliorated TAC-induced cardiac dysfunction. In contrast, cardiomyocyte-specific Hnmt overexpression caused cardiac dysfunction. Mechanistically, HNMT decreased intracellular SAM levels and interacted with enhancer of zeste homolog2 (EZH2). This interaction blocked EZH2 function and downregulated H3K27me3 modification at the Frizzled-2 (Fzd2) promoter, which increased Fzd2 expression. FZD2 upregulation activated the calcium/calciumâ€“calmodulin (CaM)-dependent protein kinase II (CaMKII) pathway, which mediated the pro-hypertrophic effects of HNMT. This study identified HNMT as a promising therapeutic target for treating pathological cardiac hypertrophy and heart failure.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307584" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE317716 è‚ é“èŒç¾¤å¯¹å£æœè¯ç‰©å¸æ”¶å’Œä»£è°¢çš„å½±å“</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolismã€gutã€regex:gut(-?microbiome)?<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Purna C Kashyap ; Krishna R Kalari ; Karunya K KandimallaSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusGut microbiota are known to influence oral drug disposition, yet the specific host pathways they affect remain poorly characterized. This study provides a transcriptome-wide characterization of how physiological gut microbiota regulate the expression of intestinal transporters, phase I and phase II metabolic enzymes, and barrier machinery relevant to oral drug disposition. By identifying microbiota-responsive processes, this work defines the scope of inter-individual variability attributable to gut microbial effects.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317716" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE316867 é™æ­¢èƒ¶è´¨æ¯ç»†èƒç˜¤æ´»åŒ–å’Œå…ç–«é€ƒé€¸çš„ä»£è°¢è®¸å¯é€šè¿‡æ˜Ÿå½¢èƒ¶è´¨ç»†èƒ-çº¿ç²’ä½“ç©¿æ¢­ [RNA-Seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€metabolicã€RNA-seq<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Hongrui Zhu ; Li Wang ; Qingsong HuSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThe reaction of quiescent tumor cell subpopulations at the invasive margin of glioblastoma (GBM) might be cleared by immune surveillance toward death or expand through immune escape, which can drive therapeutic resistance, tumor dissemination, and recurrence through phenotypic plasticity. However, the process and mechanisms underlying their activation remain largely unclear. This study revealed that astrocytes awaken quiescent GBM cells to cycling and immune-evasive phenotypes. Astrocytic mitochondria are indispensable in regulating the phenotypic changes. Specifically, the SHMT2 enzyme in astrocytic mitochondria catalyzes one-carbon metabolic products, which significantly promote synthetic metabolic activation and reactivation of quiescent GBM cells to immune evasion through intercellular mitochondrial transfer. Tumor cells that acquire astrocytic mitochondria enhanced one-carbon metabolism drives global hyperactive anabolic metabolism through YTHDC1-mediated transcriptional pause release of ribosomal and focal adhesion signaling genes, supporting rapid proliferation and conferring a potent immune-evasive phenotype. Therapeutically, pharmacologic or genetic inhibiting the astrocytic SHMT2 or blocking mitochondrial transfer markedly suppressed quiescent GBM cell activation and tumor progression. These findings elucidate a novel mechanism by which astrocytes in the tumor microenvironment drive GBM malignancy through metabolic symbiosis.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316867" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE315129 ChIP-seq åˆ†æ EZH2 å’Œ KRAS æŠ‘åˆ¶å‰‚å¤„ç†åçš„èƒ°è…ºç™Œç»†èƒä¸­ H3K27ac çš„å˜åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€ChIP-seqã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensOur study demonstrates that combined treatment with the EZH2 inhibitor tazemetostat and the KRAS inhibitor RMC-6236 markedly activates the expression of senescence-associated secretory phenotype (SASP) genes in pancreatic cancer, thereby enhancing the therapeutic efficacy of RMC-6236 and potentially providing a strategy to overcome resistance to KRAS inhibition. To characterize the epigenetic features underlying SASP gene activation, H3K27ac ChIP-seq was performed in PSN1 cells treated with DMSO, tazemetostat, RMC-6236, or the combination of both inhibitors.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315129" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 90 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (3æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨3æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>RNAæµ‹åºæ­ç¤ºé˜¿å°”èŒ¨æµ·é»˜ç—…ä¸­çš„ä»£è°¢å’Œçªè§¦å˜åŒ–</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€Alzheimerã€sequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing of blood samples reveals metabolic and synaptic gene expression changes linked to Alzheimerâ€™s disease, highlighting the importance of studying diverse populations for inclusive biomarkers...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rna-sequencing-reveals-metabolic-and-synaptic-changes-in-alzheimers-disease/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>RNAæµ‹åºæ­ç¤ºäº†ä½å‰‚é‡THCå’Œå¡æ¥æ˜”å¸ƒå¦‚ä½•æ”¹å–„é˜¿å°”èŒ¨æµ·é»˜ç—…</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimerã€sequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šRNA sequencing shows that combining low-dose THC with celecoxib shifts inflammatory and synaptic gene expression toward healthier patterns while improving cognition in Alzheimerâ€™s mouse models...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rna-sequencing-reveals-how-low-dose-thc-and-celecoxib-may-improve-alzheimers-disease/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>ç§‘å­¦å®¶å‘ç°èƒ°è…ºç™Œæ‰©æ•£çš„éšç§˜é€”å¾„</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šResearchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves, which helps cancer cells travel and form metastases. This process also creates a tough, fibrous barrier that makes treatments less effective. Targeting periostin could help stop this invasion before it starts.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2026/01/260129080432.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>24</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>12</td>
</tr>
<tr>
<td>genome</td>
<td>9</td>
</tr>
<tr>
<td>sequencing</td>
<td>8</td>
</tr>
<tr>
<td>single-cell</td>
<td>8</td>
</tr>
<tr>
<td>cardiac</td>
<td>5</td>
</tr>
<tr>
<td>tumor</td>
<td>5</td>
</tr>
<tr>
<td>spatially</td>
<td>5</td>
</tr>
<tr>
<td>immune</td>
<td>5</td>
</tr>
<tr>
<td>transcriptome</td>
<td>5</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>4</td>
</tr>
<tr>
<td>scRNA</td>
<td>4</td>
</tr>
<tr>
<td>pathway</td>
<td>4</td>
</tr>
<tr>
<td>epigenetic</td>
<td>4</td>
</tr>
<tr>
<td>ChIP-seq</td>
<td>4</td>
</tr>
<tr>
<td>genomics</td>
<td>4</td>
</tr>
<tr>
<td>Alzheimer</td>
<td>3</td>
</tr>
<tr>
<td>metabolic</td>
<td>3</td>
</tr>
<tr>
<td>spatial</td>
<td>3</td>
</tr>
<tr>
<td>spatial transcriptomics</td>
<td>3</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (90æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312012" target="_blank" rel="noopener noreferrer">GSE312012 å°¼è¾¾å°¼å¸ƒæŠ‘åˆ¶äººKRASçªå˜ç™Œç»†èƒä¸­çš„VEGFR-ERKä¿¡å·é€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285958" target="_blank" rel="noopener noreferrer">GSE285958 é‰´å®šä¸€ç§ä¸åŒæ°¢é’è’¿ç´ ç›¸å…³çš„é¢„åç‰¹å¾åŠå…¶å¯¹èƒ°è…ºç™Œè‚¿ç˜¤å¾®ç¯å¢ƒçš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315590" target="_blank" rel="noopener noreferrer">GSE315590ï¼šKLF1â€‹â€‹5ä»‹å¯¼çš„å¿ƒåŠ›è¡°ç«­å¿ƒè„ä¿æŠ¤ä½œç”¨çš„å•ç»†èƒè½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306294" target="_blank" rel="noopener noreferrer">GSE306294 RNAèšåˆé…¶IIIç»„ç»‡å’Œè‚¿ç˜¤å›¾è°±æ­ç¤ºäº†ä¸3Dè¡¨è§‚åŸºå› ç»„è°ƒæ§æœºåˆ¶ç›¸å…³çš„ç‰¹å®šç¯å¢ƒæ´»æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306220" target="_blank" rel="noopener noreferrer">GSE306220 RNAèšåˆé…¶IIIç»„ç»‡å’Œè‚¿ç˜¤å›¾è°±æ­ç¤ºäº†ä¸3Dè¡¨è§‚åŸºå› ç»„è°ƒæ§æœºåˆ¶ç›¸å…³çš„ç‰¹å®šæƒ…å¢ƒæ´»æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305800" target="_blank" rel="noopener noreferrer">GSE305800 å°é¼ ä¸‰é˜´æ€§ä¹³è…ºç™Œæ¨¡å‹å¯¹å…ç–«ç–—æ³•çš„ååº”å­˜åœ¨å·®å¼‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307583" target="_blank" rel="noopener noreferrer">GSE307583 ç»„èƒº N-ç”²åŸºè½¬ç§»é…¶å¼‚å¸¸ä¸Šè°ƒé€šè¿‡ç ´å SAM/Frizzled-2/CaMKII ä¿¡å·é€šè·¯åŠ å‰§ç—…ç†æ€§å¿ƒè„è‚¥å¤§å’Œå¿ƒåŠ›è¡°ç«­ [CUT&amp;Tag]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318153" target="_blank" rel="noopener noreferrer">GSE318153 ç”¨IL-7å’Œæ”¾å°„ç–—æ³•æ²»ç–—çš„æ”¾å°„æŠ—æ€§TC-1å°é¼ æ¨¡å‹ä¸­çš„è‚¿ç˜¤ç»†èƒå› å­è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317416" target="_blank" rel="noopener noreferrer">GSE317416 å±€éƒ¨æ—©æœŸå‰åˆ—è…ºç™Œçš„è½¬å½•ç»„ç™Œç—‡å…ç–«é€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316331" target="_blank" rel="noopener noreferrer">GSE316331 S-è…ºè‹·é«˜åŠèƒ±æ°¨é…¸æ°´è§£é…¶ç¼ºä¹é€šè¿‡è¡¨è§‚é—ä¼ è°ƒæ§ç‚ç—‡åŠ å‰§å…‹éš†1é€ è¡€å’ŒåŠ¨è„‰ç²¥æ ·ç¡¬åŒ–[äºšç¡«é…¸æ°¢ç›æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE316282" target="_blank" rel="noopener noreferrer">GSE316282 S-è…ºè‹·é«˜åŠèƒ±æ°¨é…¸æ°´è§£é…¶ç¼ºä¹ç—‡é€šè¿‡è¡¨è§‚é—ä¼ è°ƒæ§ç‚ç—‡åŠ å‰§å…‹éš†1å‹é€ è¡€å’ŒåŠ¨è„‰ç²¥æ ·ç¡¬åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311057" target="_blank" rel="noopener noreferrer">GSE311057 MÃ¼ller èƒ¶è´¨ç»†èƒ-å°èƒ¶è´¨ç»†èƒäº¤å‰å¯¹è¯é‡ç¼–ç¨‹ MÃ¼ller èƒ¶è´¨ç»†èƒè½¬å½•ç»„ï¼Œä»¥å‚ä¸è§†ç½‘è†œå†ç”Ÿè¿‡ç¨‹ä¸­çš„ç»†èƒåˆ†è£‚ç›¸å…³è¿‡ç¨‹ [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310499" target="_blank" rel="noopener noreferrer">GSE310499 å‰åˆ—è…ºç™Œä¸­ä¹™äºŒé†›é…¶ 1 è¡¨è¾¾ä¸ç”²åŸºä¹™äºŒé†›è¯±å¯¼çš„è‡´ç™Œåº”æ¿€ä¹‹é—´çš„æœºåˆ¶è”ç³»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310100" target="_blank" rel="noopener noreferrer">GSE310100 å¤šç»„å­¦åˆ†ææ­ç¤ºäº†ä¸‰é˜´æ€§ä¹³è…ºç™Œå°é¼ æ¨¡å‹ä¸­å…·æœ‰ä¸åŒåŒ–ç–—-å…ç–«æ²»ç–—è„†å¼±æ€§çš„å…ç–«åˆ†å­ç°‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309839" target="_blank" rel="noopener noreferrer">GSE309839 ä¾µè¢­æ€§å˜å¼‚å‹å‰åˆ—è…ºç™Œæ´»æ£€çš„RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304711" target="_blank" rel="noopener noreferrer">GSE304711 å¢ç”Ÿæ€§å’Œè½»åº¦å‘è‚²ä¸è‰¯æ€§å£è…”ç™½æ–‘çš„åŸºå› ç»„è§„æ¨¡ç”²åŸºåŒ–æ•°æ®</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291866" target="_blank" rel="noopener noreferrer">GSE291866 LSECsé€šè¿‡å·¨å™¬ç»†èƒæ¥æºçš„IL-1Î²è¯±å¯¼IL-1R1ä»‹å¯¼çš„è¶‹åŒ–å› å­äº§ç”Ÿä¿ƒè¿›MASHè¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288413" target="_blank" rel="noopener noreferrer">GSE288413 ç¯åˆ·è—»æŸ“è‰²ä½“çš„ 3D åŸºå› ç»„å­¦çªæ˜¾äº†æ´»æ€§è½¬å½•åœ¨æŸ“è‰²è´¨ç»„ç»‡ä¸­çš„ä½œç”¨ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287437" target="_blank" rel="noopener noreferrer">GSE287437 æ—©æœŸå‰¥å¤ºæ€§è¿‘è§†è±šé¼ çš„å•ç»†èƒRNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE283289" target="_blank" rel="noopener noreferrer">GSE283289 å¤šç»„å­¦æµ‹åºæ­ç¤ºäº†ä¸æœªç»æ²»ç–—çš„å„¿ç«¥æºƒç–¡æ€§ç»“è‚ ç‚åŸå‘æ€§ç¡¬åŒ–æ€§èƒ†ç®¡ç‚å‘å±•ç›¸å…³çš„ç‹¬ç‰¹åŸºå› è¡¨è¾¾å’Œè¡¨è§‚é—ä¼ æ”¹å˜</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE282932" target="_blank" rel="noopener noreferrer">GSE282932 é¢„å…ˆå­˜åœ¨çš„è®°å¿†Bç»†èƒè¡¨å‹å†³å®šäº†ç–«è‹—åŠ å¼ºé’ˆçš„Bç»†èƒååº”è´¨é‡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254688" target="_blank" rel="noopener noreferrer">GSE254688 æ•´åˆè½¬å½•ç»„å­¦å’Œä»£è°¢ç»„å­¦ä¸ºç´«ç«¹å˜ç§â€˜é»„èŠ±ç«¹â€™çš„å¶ç‰‡ç€è‰²æä¾›äº†æ–°çš„è§è§£</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80686" target="_blank" rel="noopener noreferrer">GSE80686 IIIç±»HD-ZIPè½¬å½•å› å­çš„å…¨åŸºå› ç»„é¶æ ‡åˆ†æ[ChIP-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80571" target="_blank" rel="noopener noreferrer">GSE80571 IIIç±»HD-ZIPè½¬å½•å› å­çš„å…¨åŸºå› ç»„é¶æ ‡åˆ†æ[RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317901" target="_blank" rel="noopener noreferrer">GSE317901 åˆ©ç”¨ APHRODYTHEï¼ˆä¸€ç§å¤šç»„å­¦æ‚£è€…æ¥æºçš„å¼‚ç§ç§»æ¤å¹³å°ï¼‰æ­ç¤ºè¥¿å¦¥æ˜”å•æŠ—åœ¨å¤´é¢ˆç™Œä¸­çš„ç–—æ•ˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312918" target="_blank" rel="noopener noreferrer">GSE312918 å¼‚æŸ“è‰²è´¨çš„è½¬å½•è°ƒæ§æ˜¯ä¸‰ç»´åŸºå› ç»„æ¥è§¦ä¸­é—ä¼ å˜å¼‚çš„åŸºç¡€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312897" target="_blank" rel="noopener noreferrer">GSE312897 å¼‚æŸ“è‰²è´¨çš„è½¬å½•è°ƒæ§æ˜¯ä¸‰ç»´åŸºå› ç»„æ¥è§¦é—ä¼ å˜å¼‚çš„åŸºç¡€ IV</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312895" target="_blank" rel="noopener noreferrer">GSE312895 å¼‚æŸ“è‰²è´¨çš„è½¬å½•è°ƒæ§æ˜¯ä¸‰ç»´åŸºå› ç»„æ¥è§¦é—ä¼ å˜å¼‚çš„åŸºç¡€ III</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312893" target="_blank" rel="noopener noreferrer">GSE312893 å¼‚æŸ“è‰²è´¨çš„è½¬å½•è°ƒæ§æ˜¯ä¸‰ç»´åŸºå› ç»„æ¥è§¦é—ä¼ å˜å¼‚çš„åŸºç¡€ II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312889" target="_blank" rel="noopener noreferrer">GSE312889 å¼‚æŸ“è‰²è´¨çš„è½¬å½•è°ƒæ§æ˜¯ä¸‰ç»´åŸºå› ç»„æ¥è§¦é—ä¼ å˜å¼‚çš„åŸºç¡€ I</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290045" target="_blank" rel="noopener noreferrer">GSE290045 ç»“ç›´è‚ ç™Œæ¥æºçš„éª¨æ¡¥è›‹ç™½é€šè¿‡PI3K/AKT/CSF1-CSF1Rè½´å°†å·¨å™¬ç»†èƒé‡å¡‘ä¸ºä¿ƒè½¬ç§»çš„M2çŠ¶æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273827" target="_blank" rel="noopener noreferrer">GSE273827 æ ¸é…¸é…¶ç¼ºé™·å‹ Cas9VPR æ¢å¤å†…æºæ€§è½¬å½•å› å­æ´»æ€§å¯é¢„é˜²åº”æ¿€æ€§å¿ƒåŠ›è¡°ç«­ II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE273656" target="_blank" rel="noopener noreferrer">GSE273656 æ ¸é…¸é…¶ç¼ºé™·å‹ Cas9VPR æ¢å¤å†…æºæ€§è½¬å½•å› å­æ´»æ€§å¯é¢„é˜²åº”æ¿€æ€§å¿ƒåŠ›è¡°ç«­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249915" target="_blank" rel="noopener noreferrer">GSE249915 FABP7 å‰ä½“ç»†èƒæ˜¯ BRCA1 ä¹³è…ºç™Œä¸­å¯é¶å‘çš„ä»£è°¢æ ¹æº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317054" target="_blank" rel="noopener noreferrer">GSE317054 é‡ç”Ÿå‹å’ŒTIGARç¼ºé™·å‹å°é¼ ç»„ç»‡ä¸­ParkinåŸºå› çš„DNAç”²åŸºåŒ–åˆ†æ[EM-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317052" target="_blank" rel="noopener noreferrer">GSE317052 é‡ç”Ÿå‹å’ŒTIGARç¼ºé™·å‹å°é¼ ç»„ç»‡ä¸­ParkinåŸºå› çš„DNAç”²åŸºåŒ–åˆ†æ[äºšç¡«é…¸æ°¢ç›æµ‹åº]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317050" target="_blank" rel="noopener noreferrer">GSE317050 RNA-seq åˆ†æé‡ç”Ÿå‹å’Œ TKO å°é¼ å¿ƒè„åœ¨æ­£å¸¸é¥²æ–™å’Œé«˜è„‚é¥®é£Ÿä¸‹ Parkin (Prkn) çš„è¡¨è¾¾ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317048" target="_blank" rel="noopener noreferrer">GSE317048 é‡ç”Ÿå‹å’Œ TigarKO å°é¼ å¿ƒè„çš„è½¬å½•ç»„åˆ†æ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314943" target="_blank" rel="noopener noreferrer">GSE314943 å•ç»†èƒå¤šç»„å­¦æ­ç¤ºå†…çš®ç»†èƒæœºæ¢°æ•æ„Ÿæ€§ PIEZO1-IL-33 è½´é©±åŠ¨è‚ºçº¤ç»´åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314709" target="_blank" rel="noopener noreferrer">GSE314709 å•ç»†èƒå¤šç»„å­¦æ­ç¤ºå†…çš®ç»†èƒæœºæ¢°æ•æ„Ÿæ€§ PIEZO1-IL-33 è½´é©±åŠ¨è‚ºçº¤ç»´åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302314" target="_blank" rel="noopener noreferrer">GSE302314 PHGDH çš„ RNA ç»“åˆæ´»æ€§é©±åŠ¨æ•£å‘æ€§é˜¿å°”èŒ¨æµ·é»˜ç—…äººè„‘ç±»å™¨å®˜æ¨¡å‹ä¸­æ·€ç²‰æ ·è›‹ç™½Î²çš„äº§ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE277881" target="_blank" rel="noopener noreferrer">GSE277881 Th1 å’Œ Th2 åˆ†åŒ–è¿‡ç¨‹ä¸­ PI3K-delta è¿‡åº¦æ´»è·ƒ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314702" target="_blank" rel="noopener noreferrer">GSE314702 åŒé¶å‘ TOP1/G4 æŠ‘åˆ¶å‰‚ ZBH-01 å¤„ç†çš„ç»“ç›´è‚ ç™Œç»†èƒçš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307184" target="_blank" rel="noopener noreferrer">GSE307184 çŒ•çŒ´å¤§è„‘ç»ˆç”Ÿå•ç»†èƒã€å¤šåŒºåŸŸåˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318248" target="_blank" rel="noopener noreferrer">GSE318248 çºµå‘å¤šç»„å­¦å›¾è°±æ­ç¤ºè€è¯æ€§é»‘è‰²ç´ ç˜¤ä¸­ç©ºé—´ç»„ç»‡å…ç–«æŠ‘åˆ¶ç”Ÿæ€ç³»ç»Ÿçš„å‡ºç° [DSP è›‹ç™½]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318201" target="_blank" rel="noopener noreferrer">GSE318201 æ¥å—æ ‡å‡†ç–—æ³•å’Œè¡¨è¾¾ HER2 çš„ææ–¯ç‰¹èŒç–«è‹—æ²»ç–—çš„éª¨è‚‰ç˜¤çŠ¬çš„å…ç–«ååº”å’Œä¸´åºŠç»“æœ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317937" target="_blank" rel="noopener noreferrer">GSE317937 çºµå‘å¤šç»„å­¦å›¾è°±æ­ç¤ºè€è¯æ€§é»‘è‰²ç´ ç˜¤ä¸­ç©ºé—´ç»„ç»‡åŒ–çš„å…ç–«æŠ‘åˆ¶ç”Ÿæ€ç³»ç»Ÿçš„å‡ºç° [nCounter RNA]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317936" target="_blank" rel="noopener noreferrer">GSE317936 çºµå‘å¤šç»„å­¦å›¾è°±æ­ç¤ºè€è¯æ€§é»‘è‰²ç´ ç˜¤ä¸­ç©ºé—´ç»„ç»‡åŒ–çš„å…ç–«æŠ‘åˆ¶ç”Ÿæ€ç³»ç»Ÿçš„å‡ºç° [nCounter è›‹ç™½]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317918" target="_blank" rel="noopener noreferrer">GSE317918 çºµå‘å¤šç»„å­¦å›¾è°±æ­ç¤ºè€è¯æ€§é»‘è‰²ç´ ç˜¤ä¸­ç©ºé—´ç»„ç»‡å…ç–«æŠ‘åˆ¶ç”Ÿæ€ç³»ç»Ÿçš„å‡ºç° [SNV]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317912" target="_blank" rel="noopener noreferrer">GSE317912 çºµå‘å¤šç»„å­¦å›¾è°±æ­ç¤ºè€è¯æ€§é»‘è‰²ç´ ç˜¤ä¸­ç©ºé—´æœ‰åºçš„å…ç–«æŠ‘åˆ¶ç”Ÿæ€ç³»ç»Ÿçš„å‡ºç°</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317695" target="_blank" rel="noopener noreferrer">GSE317695 é€šè¿‡é«˜é€šé‡æµ‹åºé‰´å®š HaCaT ç»†èƒä¸­çš„ç¥–ç»†èƒè§’è´¨å½¢æˆç»†èƒäºšç¾¤</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317583" target="_blank" rel="noopener noreferrer">GSE317583 åœ¨æ ‡å‡†å«è¡€æ¸…æ¡ä»¶ä¸‹å¯¹ 11 æ ªäººç±»èƒ¶è´¨æ¯ç»†èƒç˜¤ç»†èƒç³»è¿›è¡Œ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317455" target="_blank" rel="noopener noreferrer">GSE317455 å±€éƒ¨æ—©æœŸå‰åˆ—è…ºç™Œçš„è½¬å½•é€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317424" target="_blank" rel="noopener noreferrer">GSE317424 å±€éƒ¨æ—©æœŸå‰åˆ—è…ºç™Œçš„è½¬å½•ç»„æ³›ç™Œé€šè·¯</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317392" target="_blank" rel="noopener noreferrer">GSE317392 çµèŠé…¸Aé€šè¿‡é¶å‘RORAæŠ‘åˆ¶IL-17ä¿¡å·é€šè·¯ï¼Œä»è€Œç¼“è§£æºƒç–¡æ€§ç»“è‚ ç‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315529" target="_blank" rel="noopener noreferrer">GSE315529 RB ç¼ºå¤±é€šè¿‡è°ƒèŠ‚é»è¿è›‹ç™½ä¾èµ–æ€§ç¯å’Œå¢å¼ºå­-å¯åŠ¨å­ç›¸äº’ä½œç”¨æ¥è°ƒèŠ‚æŸ“è‰²è´¨ç»„ç»‡ [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315528" target="_blank" rel="noopener noreferrer">GSE315528 RB ç¼ºå¤±é€šè¿‡è°ƒèŠ‚é»è¿è›‹ç™½ä¾èµ–æ€§ç¯å’Œå¢å¼ºå­-å¯åŠ¨å­ç›¸äº’ä½œç”¨æ¥è°ƒèŠ‚æŸ“è‰²è´¨ç»„ç»‡ [scRNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315508" target="_blank" rel="noopener noreferrer">GSE315508 é«˜æ¸©ä¸‹èŠ±çƒ›å±æ¤ç‰©çš„è½¬å½•ç»„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315138" target="_blank" rel="noopener noreferrer">GSE315138 å•ç»†èƒ RNA æµ‹åºæ­ç¤ºä¹³ç³œæ³»åäºŒæŒ‡è‚ æ´»æ£€ä¸­ç‹¬ç‰¹çš„ç»†èƒåŠ¨åŠ›å­¦</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE315130" target="_blank" rel="noopener noreferrer">GSE315130 DMSOã€tazemetostatã€RMC-6236 æˆ–è”åˆæ²»ç–—åå¤šç§äººç±»å’Œå°é¼ èƒ°è…ºç™Œç»†èƒå’Œè‚¿ç˜¤çš„å·®å¼‚ mRNA è¡¨è¾¾åˆ†æã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314995" target="_blank" rel="noopener noreferrer">GSE314995 äºŒç¡«é”®å¯¼å‘çš„å¤šç¯è‚½ç”¨äºé¶å‘å®ä½“ç˜¤çš„åµŒåˆæŠ—åŸå—ä½“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313788" target="_blank" rel="noopener noreferrer">GSE313788 æ´»æ€§è½¬å½•åŸºå› ä¸ç»ç¼˜å…ƒä»¶ä¹‹é—´çš„åŠŸèƒ½é‡å  [ChIP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313787" target="_blank" rel="noopener noreferrer">GSE313787 æ´»æ€§è½¬å½•åŸºå› ä¸ç»ç¼˜å­å…ƒä»¶ä¹‹é—´çš„åŠŸèƒ½é‡å  [ATAC-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313785" target="_blank" rel="noopener noreferrer">GSE313785 æ´»æ€§è½¬å½•åŸºå› ä¸ç»ç¼˜å…ƒä»¶ä¹‹é—´çš„åŠŸèƒ½é‡å  [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313539" target="_blank" rel="noopener noreferrer">GSE313539 C1QBP ä¸ Dectin-1 ä¿¡å·é€šè·¯ç›¸äº’ä½œç”¨ï¼Œé€šè¿‡è¡¨è§‚é—ä¼ æ²‰é»˜æŠ‘åˆ¶å¿µç èŒæ„ŸæŸ“ä¸­çš„ IL-1Î² è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313205" target="_blank" rel="noopener noreferrer">GSE313205 è„‚æ»´å·¨å™¬ç»†èƒä¸­æŸ“è‰²è´¨å¯åŠæ€§åˆ†æï¼ˆSLC27A1 æ²‰é»˜æˆ–æœªæ²‰é»˜ï¼‰(ATAC-seq)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312994" target="_blank" rel="noopener noreferrer">GSE312994 tRF3019aæ•²ä½åH1299è‚ºè…ºç™Œç»†èƒçš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312726" target="_blank" rel="noopener noreferrer">GSE312726 é•¿é“¾éç¼–ç  RNA H19 åœ¨é˜¿æ‰èƒè‹·è€è¯çš„ K562 ç»†èƒä¸­è¿‡è¡¨è¾¾ï¼Œä½†ä¸è°ƒèŠ‚è¯ç‰©æ•æ„Ÿæ€§ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309855" target="_blank" rel="noopener noreferrer">GSE309855 è½¬ç§»æ€§å‰åˆ—è…ºç™Œæ ·æœ¬åŸºå› è¡¨è¾¾è°±çš„é‡æ–°åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309847" target="_blank" rel="noopener noreferrer">GSE309847 å‰åˆ—è…ºç™Œç±»å™¨å®˜çš„å»ºç«‹å’Œè¡¨å¾ II</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305420" target="_blank" rel="noopener noreferrer">GSE305420 RHOV æ˜¯ä¸€ç§å¯¹è„±ç¦»æœ‰ååº”çš„ Rho GTP é…¶ï¼Œæ˜¯åµå·¢ç™Œæ—©æœŸè½¬ç§»é‡ç¼–ç¨‹æ‰€å¿…éœ€çš„</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305375" target="_blank" rel="noopener noreferrer">GSE305375 åµå·¢ç™Œä¸­è„±ç¦»ååº”è½¬å½•æœ¬çš„é‰´å®š</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299935" target="_blank" rel="noopener noreferrer">GSE299935 ç©†å‹’èƒ¶è´¨ç»†èƒ-å°èƒ¶è´¨ç»†èƒç›¸äº’ä½œç”¨é‡ç¼–ç¨‹ç©†å‹’èƒ¶è´¨ç»†èƒè½¬å½•ç»„ï¼Œä»¥å‚ä¸è§†ç½‘è†œå†ç”Ÿè¿‡ç¨‹ä¸­çš„ç»†èƒåˆ†è£‚ç›¸å…³è¿‡ç¨‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288415" target="_blank" rel="noopener noreferrer">GSE288415 ç¯åˆ·è—»æŸ“è‰²ä½“çš„ä¸‰ç»´åŸºå› ç»„å­¦ç ”ç©¶çªæ˜¾äº†æ´»æ€§è½¬å½•åœ¨æŸ“è‰²è´¨ç»„ç»‡ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288411" target="_blank" rel="noopener noreferrer">GSE288411 ç¯åˆ·è—»æŸ“è‰²ä½“çš„ 3D åŸºå› ç»„å­¦çªæ˜¾äº†æ´»æ€§è½¬å½•åœ¨æŸ“è‰²è´¨ç»„ç»‡ä¸­çš„ä½œç”¨ [scNOME-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288409" target="_blank" rel="noopener noreferrer">GSE288409 ç¯åˆ·æŸ“è‰²ä½“çš„ 3D åŸºå› ç»„å­¦çªæ˜¾äº†æ´»æ€§è½¬å½•åœ¨æŸ“è‰²è´¨ç»„ç»‡ä¸­çš„ä½œç”¨ [scHi-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE287069" target="_blank" rel="noopener noreferrer">GSE287069 ç»“æ ¸åˆ†ææ†èŒä¸­ VapC36 è¿‡è¡¨è¾¾çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285993" target="_blank" rel="noopener noreferrer">GSE285993 VRK1 æ˜¯å®«é¢ˆå°ç»†èƒç¥ç»å†…åˆ†æ³Œç™Œçš„æ–°å‹æ²»ç–—é¶ç‚¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE285931" target="_blank" rel="noopener noreferrer">GSE285931 ä¸¤ç§èƒ¸è‹·é…¸åˆæˆé…¶æŠ‘åˆ¶å‰‚åœ¨ HCT116 ç»“è‚ ç™Œç»†èƒä¸­è¯±å¯¼æ˜æ˜¾ä¸åŒçš„åŸºå› ç»„å°¿å˜§å•¶æ¨¡å¼ã€è¯±å˜è¿‡ç¨‹å’Œç»†èƒååº” [GSE126822 çš„é‡æ–°åˆ†æ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281561" target="_blank" rel="noopener noreferrer">GSE281561 QKIå¤±è°ƒè¯±å¯¼Tç»†èƒæ€¥æ€§æ·‹å·´ç»†èƒç™½è¡€ç—…ï¼ˆT-ALLï¼‰ä¸­å¹¿æ³›çš„å‰ªæ¥å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE278468" target="_blank" rel="noopener noreferrer">GSE278468 Single cell mRNA sequencing of Peyer's patch LysoDCs and cDC2s and blood CD45+CD115hi cells</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE274897" target="_blank" rel="noopener noreferrer">GSE274897 å—ä½“é…ªæ°¨é…¸æ¿€é…¶ EphB2 ä¿ƒè¿›å°é¼  MASH çº¤ç»´åŒ–ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261697" target="_blank" rel="noopener noreferrer">GSE261697 äººç±»åŸä»£ã€éª¨é«“æ¥æºå’Œ iPSC æ¥æºçš„å•æ ¸ç»†èƒå’Œå·¨å™¬ç»†èƒçš„æŸ“è‰²è´¨å¯åŠæ€§ç‰¹å¾ [ATAC-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE261696" target="_blank" rel="noopener noreferrer">GSE261696 äººç±»åŸä»£ã€éª¨é«“æ¥æºå’Œ iPSC æ¥æºçš„å•æ ¸ç»†èƒå’Œå·¨å™¬ç»†èƒçš„è½¬å½•ç‰¹å¾ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254752" target="_blank" rel="noopener noreferrer">GSE254752 ç¥ç»å…ƒä¸åŒ–ç”Ÿè…ºæ³¡ç»†èƒä¹‹é—´çš„ç›¸äº’æ¿€æ´»ä½œç”¨ä¿ƒè¿›èƒ°è…ºç™Œçš„å‘ç”Ÿå’Œå‘å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE254750" target="_blank" rel="noopener noreferrer">GSE254750 RNA-Seq åˆ†æ Axonopus compressus æ ¹ç³»å¯¹é“æ¯’æ€§çš„å“åº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE225024" target="_blank" rel="noopener noreferrer">GSE225024 Terc ç¼ºä¹å¯¹è¡°è€è¿‡ç¨‹ä¸­ç ´éª¨ç»†èƒåˆ†åŒ–å’Œæˆç†Ÿçš„å½±å“[åŸ¹å…»çš¿]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99682" target="_blank" rel="noopener noreferrer">GSE99682 CD11b ç¼ºä¹å¯¼è‡´æˆç†Ÿå°è‚ å·¨å™¬ç»†èƒåŸºå› è¡¨è¾¾å˜åŒ–çš„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99672" target="_blank" rel="noopener noreferrer">GSE99672 åˆ†æ CX3CR1 ç¼ºé™·å¯¼è‡´æˆç†Ÿå°è‚ å·¨å™¬ç»†èƒåŸºå› è¡¨è¾¾å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE80687" target="_blank" rel="noopener noreferrer">GSE80687 IIIç±»HD-ZIPè½¬å½•å› å­çš„å…¨åŸºå› ç»„é¶æ ‡åˆ†æ</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-01-31 21:41</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>